| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |